. Use of Bronchoscopic Cryotherapy for Recanalization and Cryoextraction in Pediatric Population: A Five-Year Single Center Experience. American Journal of Respiratory and Critical Care Medicine. 2025; 211:a7710.
. Aligning Expectations With Outcomes: A Prospective Study of Pediatric Bronchoscopy in the ICU Setting. American Journal of Respiratory and Critical Care Medicine. 2025; 211:a2303.
. Spike and Slab Regression for Nonstationary Gaussian Linear Mixed Effects Modeling of Rapid Disease Progression. Environmetrics. 2025; 36.
. Evaluation of elexacaftor-tezacaftor-ivacaftor treatment in individuals with cystic fibrosis and CFTRN1303K in the USA: a prospective, multicentre, open-label, single-arm trial. The Lancet Respiratory Medicine. 2024; 12:947-957.
. 198 Neutrophil extracellular traps increase Pseudomonal density in human bronchial epithelia. Journal of Cystic Fibrosis. 2024; 23:s110.
. 327 Comparison of human nasal and fisher rat thyroid cell-based theratyping results. Journal of Cystic Fibrosis. 2024; 23:s173-s174.
. Quantifying abnormal alveolar microstructure in cystic fibrosis lung disease via hyperpolarized 129Xe diffusion MRI. Journal of Cystic Fibrosis. 2024; 23:926-935.
. A personalized medicine approach to optimize care for a pediatric cystic fibrosis patient with atypical clinical symptoms. Pediatric Pulmonology. 2024; 59:229-232.
. Upper Airway Disease in Cystic Fibrosis. Hodson and Geddes' Cystic Fibrosis. : Taylor & Francis; Taylor & Francis; 2023.
. 168 Impact of TGF-β exposure on IL-6 secretion in cystic fibrosis airway epithelia. Journal of Cystic Fibrosis. 2023; 22:s89.
. 98 Neutrophil extracellular traps disrupt bronchial epithelial junctional integrity and promote infection. Journal of Cystic Fibrosis. 2023; 22:s51.
. Gradual increase in sweat chloride concentration is associated with a higher risk of CRMS/CFSPID to CF reclassification. Pediatric Pulmonology. 2023; 58:1074-1084.
. Alpha-1 antitrypsin limits neutrophil extracellular trap disruption of airway epithelial barrier function. Frontiers in Immunology. 2023; 13:1023553.
. Phenotypic Alteration of an Established Human Airway Cell Line by Media Selection. International Journal of Molecular Sciences. 2023; 24:1246.
. Novel Applications of Biomarkers and Personalized Medicine in Cystic Fibrosis. Clinics in Chest Medicine. 2022; 43:617-630.
. 606 Focused clinical trials of modulator response for rare cystic fibrosis genotypes. Journal of Cystic Fibrosis. 2022; 21:s336.
. 380 Neutrophil extracellular traps disrupt bronchial epithelial barrier function: Alpha-1 antitrypsin to the rescue. Journal of Cystic Fibrosis. 2022; 21:s223.
. 683 Characteristics of cystic fibrosis transmembrane conductance regulator modulator response in nasal cell models derived from patients with rare cystic fibrosis transmembrane conductance regulator variants. Journal of Cystic Fibrosis. 2022; 21:s373.
. CRISPRi links COVID-19 GWAS loci to LZTFL1 and RAVER1. EBioMedicine. 2022; 75:103806.
. When CFSPID becomes CF. Journal of Cystic Fibrosis. 2022; 21:e23-e27.
. Rapid cystic fibrosis lung-function decline and in-vitro CFTR modulation. Journal of Cystic Fibrosis. 2021; 20:e69-e71.
. Pediatric flexible airway endoscopy training during a pandemic and beyond: Bending the curve. Pediatric Pulmonology. 2021; 56:1386-1388.
. Patient personalized translational tools in cystic fibrosis to transform data from bench to bed-side and back. American Journal of Physiology: Gastrointestinal and Liver Physiology. 2021; 320:G1123-G1130.
. Nasal Epithelial Cell-Based Models for Individualized Study in Cystic Fibrosis. International Journal of Molecular Sciences. 2021; 22:4448.
. Flexible Bronchoscopic Thrombus Cryoextraction in a Neonate on Extracorporeal Membrane Oxygenation. American Journal of Respiratory and Critical Care Medicine. 2021; 203:633-635.